Volume 24, Number 3—March 2018
Dispatch
Seroprevalence of Dengue and Chikungunya Virus Antibodies, French Polynesia, 2014–2015
Table 2
Participant ID |
Years in French Polynesia |
Virus |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dengue 1 | Dengue 2 | Dengue 3 | Dengue 4 | Chikungunya | Zika‡ | |||||||||||||
MIA |
NTA† |
MIA |
NTA |
MIA |
NTA |
MIA |
NTA |
MIA |
NTA |
MIA‡ |
NTA |
|||||||
Pueu-6 | 1 | – | <10 | – | <10 | – | <10 | – | <10 | + | 80 | – | <10 | |||||
Papeete-62 | 2 | – | <10 | – | <10 | – | <10 | – | <10 | – | <10 | – | 10 | |||||
Papeete-63 | 2 | – | <10 | – | <10 | – | <10 | – | <10 | – | <10 | – | 40 | |||||
Papeete-35 | 6 | – | <10 | – | <10 | – | <10 | – | <10 | – | <10 | – | 20 | |||||
Punaauia-96 | 6 | – | <10 | – | <10 | – | <10 | – | <10 | – | <10 | – | 10 | |||||
Pirae-6 | 10 | – | <10 | – | <10 | – | <10 | – | 80 | – | <10 | + | 160 | |||||
Mahina-26 | 13 | – | <10 | – | <10 | – | <10 | – | <10 | + | 320 | + | 160 | |||||
Punaauia-61 | 15 | – | 640 | – | <10 | – | <10 | – | <10 | – | <10 | – | <10 | |||||
Faaa-54 | 17 | + | 10 | – | <10 | – | <10 | – | <10 | + | 160 | + | >1,280 | |||||
Toahotu-1 | 18 | – | <10 | – | <10 | – | <10 | + | 80 | – | <10 | – | <10 | |||||
Punaauia-93 | 21 | – | <10 | – | 640 | – | <10 | – | <10 | – | <10 | – | 20 | |||||
Punaauia-36 | 24 | – | 40 | – | 640 | – | 40 | – | 80 | + | 160 | – | 20 | |||||
Papenoo-10 | 28 | + | 640 | + | >1,280 | + | >1,280 | + | 640 | – | <10 | – | <10 | |||||
Moorea-59 | 36 | + | 320 | – | <10 | + | >1,280 | + | >1,280 | – | <10 | + | 640 | |||||
Paea-48 | 38 | + | 160 | – | <10 | – | 80 | – | 80 | – | <10 | + | 160 | |||||
Papeari-17 | 44 | + | 320 | + | >1,280 | + | 80 | + | 160 | + | 20 | + | 320 | |||||
Papenoo-1 | 49 | + | 160 | + | >1,280 | + | 20 | + | 80 | + | 640 | + | <10 | |||||
Faaa-22 | 54 | + | 80 | + | 640 | – | 320 | – | 160 | + | 40 | – | <10 | |||||
Papeete-10 | 55 | + | 320 | + | >1,280 | + | 80 | + | 640 | + | <10 | + | 160 | |||||
Afaahiti-7 | 67 | + | 80 | – | 640 | + | 320 | – | 160 | – | <10 | – | <10 |
*ID, identification; MIA, microsphere immunoassay; NTA, neutralization assay; +, positive; –, negative.
†Neutralization activity was considered positive for serum samples with a 50% neutralization antibody titer >20.
‡Results from Aubry et al. (7).
Page created: February 16, 2018
Page updated: February 16, 2018
Page reviewed: February 16, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.